Marker Therapeutics Inc (MRKR) stock news · rev $3.5M
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
This MRKR news page leads with what Marker Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for MRKR yet. We will not pad this page with generic market recap.
Latest reported MRKR revenue for 2025-12-31 was $3.5M. Net income was -$12.2M. Revenue was down 46.2% from 2024-12-31 to 2025-12-31. MRKR currently screens at market cap $25.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MRKR stock page; for the tape open the quote page.
MRKR stock news FAQ
What are MRKR's latest revenue and net income?
Latest cached Marker Therapeutics Inc (MRKR) revenue for Dec 31, 2025 was $3.5M. Net income was -$12.2M. Statements: https://lician.com/financials/mrkr
How did MRKR revenue change from the prior cached period?
Cached Marker Therapeutics Inc (MRKR) revenue was down 46.2% from $6.6M (Dec 31, 2024) to $3.5M (Dec 31, 2025). Statements: https://lician.com/financials/mrkr
What is MRKR's market cap?
Marker Therapeutics Inc (MRKR) market cap is $25.3M on the latest cached fundamentals snapshot.
What kind of company is MRKR?
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Where is MRKR stock news listed?
Cached stock news for Marker Therapeutics Inc (MRKR) is listed at https://lician.com/news/mrkr. Filings: https://lician.com/sec/mrkr
Not investment advice.